- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
CNMD
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
CONMED Corporation · Healthcare · Medical Devices
Latest close
42.68 USD
-1.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned -1.2%, after a 18.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 38/100 conviction, while the latest news-sentiment score is 55/100.
Setup score
44
out of 100
Latest Close
42.68 USD
24 Jul 2026
1W Return
-1.2%
latest completed week
4W Return
18.7%
short-term follow-through
12W Return
16.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.64% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.2%
Latest completed week; four-week move 18.7%.
Indicator stack
0/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.64%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
38/100 conviction; expected move 9.5%.
News sentiment
55/100
69 relevant articles in the latest sentiment read.
Event risk
29 Jul
Latest stored earnings date was 29 Jul 2026.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned -1.2%, after a 18.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1912-week average 0.08
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 18.7% over four weeks, 16.0% over 12 weeks, and -15.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.35Latest activity-pressure read.
Pressure change625.3%Four-week change in activity pressure.
Leadership-6.78Latest relative-leadership reading.
RS change70.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength46/100Blend of value, momentum, and quality. Underlying universe rank 55; rank 1 is best.
Value73/100Relative valuation strength. Underlying universe rank 28; rank 1 is best.
Quality28/100Profitability and accounting quality. Underlying universe rank 73; rank 1 is best.
Momentum16/100Medium-term price momentum. Underlying universe rank 85; rank 1 is best.
Growth29/100Revenue and earnings growth. Underlying universe rank 72; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework48/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 23.4x Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 12.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 7.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 53.6% Gross profit retained from each unit of revenue.
- Operating margin
- 8.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 11.8% Free cash flow generated from revenue.
- Return on invested capital
- 4.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.4% Latest one-year revenue growth.
- EPS growth
- -53.8% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -16.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 4.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
CNMD shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of 1.48, expected move of 9.5%, and Sharemaestro trend signal inactive.
Conviction38/100
Expected move9.5%
Put/call volume1.48
Insider activity15 / 5
15 acquisitions and 5 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment55/100
Weighted news tone is neutral across 69 relevant articles.
16 positive · 51 neutral · 2 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings29 JulLatest stored earnings date was 29 Jul 2026.
Options expected move9.5%Nearest-chain priced movement where available.
52-week drawdown-24.3%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher11 of 2615 weeks finished lower.
Best week+13.7%Week of 10 Jul.
Worst week-13.3%Week of 6 Mar.
Latest week-1.2%Week of 24 Jul.
Shape of recent returns
Strong gains8
Modest gains3
Flat weeks0
Modest losses8
Sharp losses7
Recent vol6.7%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average-0.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD74.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Devices
4-week rank4 / 100
Group average-3.5%
Trend breadth35.0%
Trend35.0%active weekly trend signals
MD64.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis21/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.19; No reversal markers Next-Week ExpectancyNegative 43.64%Next-week expectancy is negative with a 43.64% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 63; Small Cap Core rank 34 SVQF48/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 528.0 of 1013 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Options58/100CNMD shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of 1.48, expected move of 9.5%, and Sharemaestro trend signal inactive.
Mixed · Options-market disagreement · Expected move 9.5% Sentiment55/100Weighted news tone is neutral across 69 relevant articles.
Stocks making big moves this week: Huron, Sherwin-Williams, PROG, CONMED, and Freshworks Insiders15 / 515 acquisitions and 5 disposals in the latest 180-day insider tape.
Earnings29 JulLatest stored earnings date was 29 Jul 2026.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 42.68 USD | -1.2% | 38.49 USD | 64.34 USD | 1.35 | -6.78 | 3.0M | Off |
| 17 Jul 2026 | 43.20 USD | 12.3% | 38.43 USD | 64.81 USD | 1.25 | -6.86 | 5.6M | Off |
| 10 Jul 2026 | 38.48 USD | 13.7% | 38.32 USD | 65.30 USD | 0.75 | -18.78 | 4.3M | Off |
| 3 Jul 2026 | 33.83 USD | -5.9% | 38.40 USD | 65.89 USD | 0.26 | -28.31 | 2.0M | Off |
| 26 Jun 2026 | 35.95 USD | 10.3% | 38.61 USD | 66.50 USD | 0.19 | -23.15 | 3.3M | Off |
| 19 Jun 2026 | 32.58 USD | -6.3% | 38.86 USD | 67.12 USD | -0.30 | -32.74 | 3.2M | Off |
| 12 Jun 2026 | 34.77 USD | -1.1% | 39.20 USD | 67.73 USD | -0.30 | -28.50 | 2.4M | Off |
| 5 Jun 2026 | 35.16 USD | -1.5% | 39.44 USD | 68.36 USD | -0.42 | -28.21 | 3.0M | Off |
| 29 May 2026 | 35.70 USD | -4.1% | 39.73 USD | 68.96 USD | -0.37 | -29.90 | 1.7M | Off |
| 22 May 2026 | 37.23 USD | 4.9% | 40.01 USD | 69.52 USD | -0.17 | -26.86 | 2.2M | Off |
| 15 May 2026 | 35.49 USD | -3.5% | 40.36 USD | 70.02 USD | -0.21 | -30.57 | 1.9M | Off |
| 8 May 2026 | 36.76 USD | -0.1% | 40.68 USD | 70.54 USD | -0.13 | -29.00 | 2.4M | Off |
| 1 May 2026 | 36.80 USD | -4.0% | 40.88 USD | 71.05 USD | -0.27 | -28.26 | 3.0M | Off |
| 24 Apr 2026 | 38.34 USD | -1.9% | 41.26 USD | 71.60 USD | -0.51 | -25.59 | 1.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.